Elevated plasma urokinase receptor predicts low birth weight in maternal malaria

S R Ostrowski; C E Shulman; N Peshu; Trine Staalsø; G Høyer-Hansen; B K Pedersen; K Marsh; H Ullum

doi:10.1111/j.1365-3024.2006.00916.x

Elevated plasma urokinase receptor predicts low birth weight in maternal malaria

S R Ostrowski, C E Shulman, N Peshu, Trine Staalsø, G Høyer-Hansen, B K Pedersen, K Marsh, H Ullum

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

17 Citationer (Scopus)

Abstract

Udgivelsesdato: 2007-Jan

Originalsprog	Engelsk
Tidsskrift	Parasite Immunology
Vol/bind	29
Udgave nummer	1
Sider (fra-til)	37-46
Antal sider	9
ISSN	0141-9838
DOI	https://doi.org/10.1111/j.1365-3024.2006.00916.x
Status	Udgivet - 2007

Bibliografisk note

Keywords: Adult; Animals; Biological Markers; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator

Adgang til dokumentet

10.1111/j.1365-3024.2006.00916.x

Citationsformater

@article{c72a8c300ce611df825d000ea68e967b,

title = "Elevated plasma urokinase receptor predicts low birth weight in maternal malaria",

abstract = "The blood level of soluble urokinase receptor (suPAR) is increased and associated with a poor clinical or fatal outcome in children with acute malaria. This study hypothesized that the suPAR level would be associated with foetal outcome in maternal malaria. suPAR was measured by ELISA in maternal and cord plasma samples taken during delivery in 253 pregnant Kenyan women stratified according to placental histology: no malaria infection (non-infected), active or active-chronic infection (actively infected) or past-chronic infection (past-infected). Maternal-suPAR was higher in actively infected women (median 3.93 (IQR 2.92-5.29) ng/mL) compared with non-infected (median 2.78 (IQR 1.86-3.87) ng/mL, P = 0.001) and past-infected (median 2.67 (IQR 1.94-3.7) ng/mL, P = 0.012) women. Cord-suPAR was comparable across the groups (median 2.98 (IQR 2.38-3.77) ng/mL). In actively infected women, maternal-suPAR and gestational age were the only independent predictors of birth weight in multivariate linear regression adjusted for maternal-suPAR, HIV-1 infection, age, BMI, haemoglobin, peripheral parasitaemia, parity and gestational age; 1 ng/mL higher maternal-suPAR predicted -56 g (95% CI -100 to -12, P = 0.016) reduced birth weight. Cord-suPAR could not predict birth weight after adjusting for gestational age. Future studies are warranted to investigate whether the maternal suPAR level is increased earlier in pregnancy in women with active placental malaria infection and whether early maternal suPAR measurements can predict birth weight. If so, measurements of maternal suPAR early in pregnancy might then potentially identify women with increased needs for antenatal care and intervention.",

author = "Ostrowski, {S R} and Shulman, {C E} and N Peshu and Trine Staals{\o} and G H{\o}yer-Hansen and Pedersen, {B K} and K Marsh and H Ullum",

note = "Keywords: Adult; Animals; Biological Markers; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator",

year = "2007",

doi = "10.1111/j.1365-3024.2006.00916.x",

language = "English",

volume = "29",

pages = "37--46",

journal = "Parasite Immunology",

issn = "0141-9838",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Elevated plasma urokinase receptor predicts low birth weight in maternal malaria

AU - Ostrowski, S R

AU - Shulman, C E

AU - Peshu, N

AU - Staalsø, Trine

AU - Høyer-Hansen, G

AU - Pedersen, B K

AU - Marsh, K

AU - Ullum, H

N1 - Keywords: Adult; Animals; Biological Markers; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator

PY - 2007

Y1 - 2007

N2 - The blood level of soluble urokinase receptor (suPAR) is increased and associated with a poor clinical or fatal outcome in children with acute malaria. This study hypothesized that the suPAR level would be associated with foetal outcome in maternal malaria. suPAR was measured by ELISA in maternal and cord plasma samples taken during delivery in 253 pregnant Kenyan women stratified according to placental histology: no malaria infection (non-infected), active or active-chronic infection (actively infected) or past-chronic infection (past-infected). Maternal-suPAR was higher in actively infected women (median 3.93 (IQR 2.92-5.29) ng/mL) compared with non-infected (median 2.78 (IQR 1.86-3.87) ng/mL, P = 0.001) and past-infected (median 2.67 (IQR 1.94-3.7) ng/mL, P = 0.012) women. Cord-suPAR was comparable across the groups (median 2.98 (IQR 2.38-3.77) ng/mL). In actively infected women, maternal-suPAR and gestational age were the only independent predictors of birth weight in multivariate linear regression adjusted for maternal-suPAR, HIV-1 infection, age, BMI, haemoglobin, peripheral parasitaemia, parity and gestational age; 1 ng/mL higher maternal-suPAR predicted -56 g (95% CI -100 to -12, P = 0.016) reduced birth weight. Cord-suPAR could not predict birth weight after adjusting for gestational age. Future studies are warranted to investigate whether the maternal suPAR level is increased earlier in pregnancy in women with active placental malaria infection and whether early maternal suPAR measurements can predict birth weight. If so, measurements of maternal suPAR early in pregnancy might then potentially identify women with increased needs for antenatal care and intervention.

AB - The blood level of soluble urokinase receptor (suPAR) is increased and associated with a poor clinical or fatal outcome in children with acute malaria. This study hypothesized that the suPAR level would be associated with foetal outcome in maternal malaria. suPAR was measured by ELISA in maternal and cord plasma samples taken during delivery in 253 pregnant Kenyan women stratified according to placental histology: no malaria infection (non-infected), active or active-chronic infection (actively infected) or past-chronic infection (past-infected). Maternal-suPAR was higher in actively infected women (median 3.93 (IQR 2.92-5.29) ng/mL) compared with non-infected (median 2.78 (IQR 1.86-3.87) ng/mL, P = 0.001) and past-infected (median 2.67 (IQR 1.94-3.7) ng/mL, P = 0.012) women. Cord-suPAR was comparable across the groups (median 2.98 (IQR 2.38-3.77) ng/mL). In actively infected women, maternal-suPAR and gestational age were the only independent predictors of birth weight in multivariate linear regression adjusted for maternal-suPAR, HIV-1 infection, age, BMI, haemoglobin, peripheral parasitaemia, parity and gestational age; 1 ng/mL higher maternal-suPAR predicted -56 g (95% CI -100 to -12, P = 0.016) reduced birth weight. Cord-suPAR could not predict birth weight after adjusting for gestational age. Future studies are warranted to investigate whether the maternal suPAR level is increased earlier in pregnancy in women with active placental malaria infection and whether early maternal suPAR measurements can predict birth weight. If so, measurements of maternal suPAR early in pregnancy might then potentially identify women with increased needs for antenatal care and intervention.

U2 - 10.1111/j.1365-3024.2006.00916.x

DO - 10.1111/j.1365-3024.2006.00916.x

M3 - Journal article

C2 - 17187653

SN - 0141-9838

VL - 29

SP - 37

EP - 46

JO - Parasite Immunology

JF - Parasite Immunology

IS - 1

ER -